2C-T-31

From WikiMD's Wellness Encyclopedia

A synthetic psychedelic compound



2C-T-31 is a synthetic psychedelic compound belonging to the 2C family of phenethylamines. It is structurally related to other compounds in the 2C-T series, which are known for their psychoactive properties. 2C-T-31 was first synthesized by the chemist Alexander Shulgin, who documented it in his book PiHKAL (Phenethylamines I Have Known And Loved).

Chemical Structure and Properties[edit | edit source]

2C-T-31 is chemically classified as a phenethylamine, with the full IUPAC name being 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine. The compound features a phenyl ring substituted with two methoxy groups at the 2 and 5 positions, and an isopropylthio group at the 4 position. This structure is similar to other compounds in the 2C-T series, such as 2C-T-7 and 2C-T-2.

Pharmacology[edit | edit source]

The pharmacological effects of 2C-T-31 are not well-documented, as it has not been extensively studied in humans or animals. However, based on its structural similarity to other 2C-T compounds, it is presumed to act as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is known to mediate the psychedelic effects of many related compounds.

Effects[edit | edit source]

The subjective effects of 2C-T-31 are largely anecdotal, as it has not been widely used or studied. Users have reported effects typical of psychedelics, including altered perception, visual hallucinations, and changes in thought processes. The duration and intensity of these effects can vary depending on the dose and individual sensitivity.

Safety and Toxicity[edit | edit source]

Due to the lack of scientific research, the safety profile of 2C-T-31 is not well understood. As with other research chemicals, there is a potential risk of adverse effects, and it should be approached with caution. Users should be aware of the potential for unknown toxicological effects and the lack of established dosing guidelines.

Legal Status[edit | edit source]

As of the last update, 2C-T-31 is not specifically listed as a controlled substance in most jurisdictions. However, it may be subject to analogue laws that regulate compounds similar to controlled substances. Researchers and users should verify the legal status in their specific region before handling or using this compound.

History[edit | edit source]

2C-T-31 was first synthesized by Alexander Shulgin, who included it in his comprehensive work on phenethylamines, PiHKAL. Shulgin's work has been instrumental in the exploration of psychedelic compounds, and 2C-T-31 is one of many substances he synthesized and documented.

See Also[edit | edit source]



WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD